Biocon Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Biocon kazanç ve gelirin sırasıyla yıllık 7.2% ve 15.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 7.2% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 6.3% olacağı tahmin edilmektedir.

Anahtar bilgiler

7.2%

Kazanç büyüme oranı

7.2%

EPS büyüme oranı

Biotechs kazanç büyümesi48.8%
Gelir büyüme oranı15.3%
Gelecekteki özkaynak getirisi6.3%
Analist kapsamı

Good

Son güncelleme03 Nov 2024

Gelecekteki son büyüme güncellemeleri

Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Nov 02
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Feb 12
Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Recent updates

Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Nov 02
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Nov 01
Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

Oct 14
Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Sep 20
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Jun 29
Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors

Is Biocon (NSE:BIOCON) A Risky Investment?

Jun 11
Is Biocon (NSE:BIOCON) A Risky Investment?

Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Jun 11
Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50

Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

May 24
Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations

Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

May 23
Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50

Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Mar 20
Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Feb 12
Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next

Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Jan 23
Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price

Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

Jan 03
Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Nov 13
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Aug 03
Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Jul 03
Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 02
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

May 26
Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50

Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Mar 28
Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)

Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Feb 26
Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly

Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Dec 17
Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate

Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Sep 05
Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?

Is Biocon (NSE:BIOCON) Using Too Much Debt?

Jul 13
Is Biocon (NSE:BIOCON) Using Too Much Debt?

Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

May 26
Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate

Kazanç ve Gelir Büyüme Tahminleri

NSEI:BIOCON - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
3/31/2027214,00616,50827,40240,00311
3/31/2026183,48211,90122,76934,22616
3/31/2025153,17310,97716,66033,19516
9/30/2024148,94114,39221,04540,368N/A
6/30/2024147,66015,808N/AN/AN/A
3/31/2024147,55710,22510,22329,539N/A
12/31/2023146,12512,002N/AN/AN/A
9/30/2023135,9994,984-6,24111,717N/A
6/30/2023124,5734,197N/AN/AN/A
3/31/2023111,7424,6271,26218,525N/A
12/31/202298,0913,881N/AN/AN/A
9/30/202290,4226,170-6,83611,543N/A
6/30/202285,6297,084N/AN/AN/A
3/31/202281,8406,484-7,48211,766N/A
12/31/202175,8006,727N/AN/AN/A
9/30/202172,6326,542-6,36612,763N/A
6/30/202171,7266,852N/AN/AN/A
3/31/202171,4317,405-5,86611,597N/A
12/31/202068,9135,996N/AN/AN/A
9/30/202067,5716,362-6,57610,484N/A
6/30/202065,7966,870N/AN/AN/A
3/31/202063,0057,771-5,53412,831N/A
12/31/201963,1508,385N/AN/AN/A
9/30/201961,0778,529-3,41614,573N/A
6/30/201958,5659,919N/AN/AN/A
3/31/201955,1449,053-3,37411,546N/A
12/31/201851,5518,220N/AN/AN/A
9/30/201846,7226,967N/AN/AN/A
6/30/201843,1984,108N/AN/AN/A
3/31/201841,2343,724N/A6,621N/A
12/31/201738,7923,695N/AN/AN/A
9/30/201738,5894,489N/AN/AN/A
6/30/201738,3615,268N/AN/AN/A
3/31/201738,9116,121N/A6,400N/A
12/31/201640,48711,633N/AN/AN/A
9/30/201638,11010,961N/AN/AN/A
6/30/201636,5399,388N/AN/AN/A
3/31/201633,4745,504N/A3,706N/A
12/31/201532,9977,367N/AN/AN/A
9/30/201532,3257,247N/AN/AN/A
6/30/201531,5285,207N/AN/AN/A
3/31/201530,8984,974N/A2,107N/A
12/31/201429,8074,091N/AN/AN/A
9/30/201429,1684,231N/AN/AN/A
6/30/201429,0144,232N/AN/AN/A
3/31/201428,7734,138N/A5,607N/A
12/31/201328,1805,493N/AN/AN/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: BIOCON 'nin tahmini kazanç büyümesi (yıllık 7.2% ) tasarruf oranının ( 6.7% ) üzerindedir.

Kazançlar ve Piyasa: BIOCON şirketinin kazançlarının (yıllık 7.2% ) Indian pazarından (yıllık 17.9% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: BIOCON şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: BIOCON şirketinin gelirinin (yıllık 15.3% ) Indian pazarından (yıllık 10.3% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: BIOCON şirketinin gelirinin (yıllık 15.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: BIOCON 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 6.3 %).


Büyüyen şirketleri keşfedin